VanEck Biotech ETF (BBH) is an ETF managed by Independent / Boutique. Its largest position is GILEAD SCIENCES, INC. (GILD), representing 14.63% of fund assets.
VanEck Biotech ETF Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- BBH
- Type:
- ETF
- Manager:
- Independent / Boutique
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- May 28, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
GILEAD SCIENCES, INC.
|
14.63% | $54,367,122.04 | 390,092 |
|
-
AMGEN INC
|
14.54% | $54,037,826.70 | 153,582 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
8.06% | $29,941,846.62 | 67,053 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
7.51% | $27,917,028.48 | 36,132 |
|
-
ARGENX SE
|
5.28% | $19,608,673.00 | 26,852 |
|
-
INSMED Inc
|
4.59% | $17,053,500.80 | 104,290 |
|
-
IQVIA HOLDINGS INC.
|
4.30% | $15,971,241.54 | 93,651 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
4.11% | $15,259,724.40 | 46,120 |
|
-
Natera, Inc.
|
3.98% | $14,785,460.69 | 73,931 |
|
-
UNITED THERAPEUTICS Corp
|
3.81% | $14,146,130.88 | 23,856 |
|
-
BIOGEN INC.
|
3.72% | $13,830,965.19 | 75,443 |
|
-
BeOne Medicines Ltd.
|
3.25% | $12,063,515.34 | 40,622 |
|
-
Moderna, Inc.
|
3.10% | $11,527,028.00 | 226,910 |
|
-
Revolution Medicines, Inc.
|
2.86% | $10,635,746.25 | 109,365 |
|
-
ILLUMINA, INC.
|
2.49% | $9,260,893.58 | 75,133 |
|
-
INCYTE CORP
|
2.25% | $8,354,655.92 | 88,766 |
|
-
BioNTech SE
|
2.15% | $8,006,043.76 | 90,077 |
|
-
NEUROCRINE BIOSCIENCES INC
|
1.94% | $7,196,692.72 | 54,628 |
|
-
BIOMARIN PHARMACEUTICAL INC
|
1.39% | $5,174,314.53 | 91,597 |
|
-
BIO-TECHNE Corp
|
1.35% | $5,006,664.78 | 95,803 |
|
-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
|
1.28% | $4,750,477.50 | 27,539 |
|
-
ICON PLC
|
1.27% | $4,727,173.88 | 42,718 |
|
-
QIAGEN NV
|
1.15% | $4,256,612.36 | 106,309 |
|
-
Tempus AI, Inc.
|
0.93% | $3,444,633.50 | 76,175 |
|
-
STATE STREET GLOBAL ADVISORS
|
0.23% | $853,192.75 | 853,193 |
Advertisement (320x50)